HIV molecular immunology database

 

Search CTL/CD8+ T-Cell Epitope Database

Found 13 matching records:

Displaying record number 62493

Download this epitope record as JSON.

HXB2 Location Gag(18-26)
p17(18-26)
DNA(841..867)
Gag Epitope Map
Author Location Gag(18-26)
Epitope KIRLRPGGK Epitope Alignment
KIRLRPGGK epitope logo
Epitope Name KK9
Species (MHC/HLA) human(A*03)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62494

Download this epitope record as JSON.

HXB2 Location Gag(20-29)
p17(20-29)
DNA(847..876)
Gag Epitope Map
Author Location Gag(20-29)
Epitope RLRPGGKKKY Epitope Alignment
RLRPGGKKKY epitope logo
Epitope Name RY10
Species (MHC/HLA) human(B*15)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62487

Download this epitope record as JSON.

HXB2 Location Gag(77-85)
p17(77-85)
DNA(1018..1044)
Gag Epitope Map
Author Location Gag(77-85)
Epitope SLYNTVATL Epitope Alignment
SLYNTVATL epitope logo
Epitope Name SL9
Species (MHC/HLA) human(A*02)
Immunogen in vitro stimulation or selection, engineered
Experimental methods CD8 T-cell Elispot - IFNγ, CTL suppression of replication, Chromium-release assay, Peptide titration
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells, neutralization by CTL

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62497

Download this epitope record as JSON.

HXB2 Location Gag(147-155)
p24(15-23)
DNA(1228..1254)
Gag Epitope Map
Author Location Gag(147-155)
Epitope ISPRTLNAW Epitope Alignment
ISPRTLNAW epitope logo
Epitope Name IW9
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62500

Download this epitope record as JSON.

HXB2 Location Gag(162-172)
p24(30-40)
DNA(1273..1305)
Gag Epitope Map
Author Location Gag(162-172)
Epitope KAFSPEVIPMF Epitope Alignment
KAFSPEVIPMF epitope logo
Epitope Name KF11
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection, engineered, virus
Experimental methods CTL suppression of replication, Chromium-release assay, Peptide titration
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells, neutralization by CTL

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62498

Download this epitope record as JSON.

HXB2 Location Gag(240-249)
p24(108-117)
DNA(1507..1536)
Gag Epitope Map
Author Location Gag(240-249)
Epitope TSTLQEQIGW Epitope Alignment
TSTLQEQIGW epitope logo
Epitope Name TW10
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay, Peptide titration
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62504

Download this epitope record as JSON.

HXB2 Location Pol(357-365)
RT(202-210)
DNA(3153..3179)
Pol Epitope Map
Author Location Pol(357-365)
Epitope IEELRQHLL Epitope Alignment
IEELRQHLL epitope logo
Epitope Name IL9
Species (MHC/HLA) human(B*40)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62496

Download this epitope record as JSON.

HXB2 Location Pol(464-472)
RT(309-317)
DNA(3474..3500)
Pol Epitope Map
Author Location Pol(464-472)
Epitope ILKEPVHGV Epitope Alignment
ILKEPVHGV epitope logo
Epitope Name IV9
Species (MHC/HLA) human(A*02)
Immunogen in vitro stimulation or selection, engineered
Experimental methods CTL suppression of replication, Chromium-release assay, Peptide titration
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells, neutralization by CTL

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62502

Download this epitope record as JSON.

HXB2 Location Pol(529-538)
RT(374-383)
DNA(3669..3698)
Pol Epitope Map
Author Location Pol(529-538)
Epitope KIATESIVIW Epitope Alignment
KIATESIVIW epitope logo
Epitope Name KW10
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62503

Download this epitope record as JSON.

HXB2 Location Rev(14-23)
DNA(6009..6038)
Rev Epitope Map
Author Location Rev(14-23)
Epitope RTVRLIKLLY Epitope Alignment
RTVRLIKLLY epitope logo
Epitope Name RY10
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62501

Download this epitope record as JSON.

HXB2 Location Nef(116-125)
DNA(9142..9171)
Nef Epitope Map
Author Location Nef(116-125)
Epitope HTQGYFPDWQ Epitope Alignment
HTQGYFPDWQ epitope logo
Epitope Name HQ10
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay, Peptide titration
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62495

Download this epitope record as JSON.

HXB2 Location Nef(117-127)
DNA(9145..9177)
Nef Epitope Map
Author Location Nef(117-127)
Epitope TQGYFPDWQNY Epitope Alignment
TQGYFPDWQNY epitope logo
Epitope Name TY11
Species (MHC/HLA) human(B*15)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Displaying record number 62499

Download this epitope record as JSON.

HXB2 Location Nef(120-128)
DNA(9154..9180)
Nef Epitope Map
Author Location Nef(120-128)
Epitope YFPDWQNYT Epitope Alignment
YFPDWQNYT epitope logo
Epitope Name YT9
Species (MHC/HLA) human(B*57)
Immunogen in vitro stimulation or selection
Experimental methods Chromium-release assay
Keywords assay or method development, variant cross-reactivity, characterizing CD8+ T cells

Notes

References

Balamurugan2018 Arumugam Balamurugan, Hwee L. Ng, and Otto O. Yang. Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones. J. Virol., 92(16), 15 Aug 2018. PubMed ID: 29899094. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health